EGF and cholestasis: In pathological conditions like cholestasis and fibrosis, EGF may impact the balance between cholangiocytes and hepatocytes by modulating β-catenin activity (Okabe et al., 2016; Russell and Monga, 2018; Lee et al., 2010).